Breast cancer patients who smoke are at risk for more complications after surgery (such as delayed wound healing and infections) than nonsmokers. This study is assessing two approaches to help breast cancer patients stop smoking before mastectomy and breast reconstruction surgery.
Patients will be randomly assigned to one of two groups. One group will receive the smoking cessation drug varenicline (marketed as Chantix), and the other will receive a placebo. Both groups will also receive smoking cessation counseling. Researchers hope the results of this study will help improve smoking cessation treatment for breast cancer patients scheduled for surgery.